{"transactions":[{"id":706038,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":29597,"kind":"person","name":"Issa Mohamed Khairie","position":1,"cik":"0002050035","reported_name":"Issa Mohamed Khairie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Head of U.S. Commercial"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-07-20T20:09:16.000Z","date":"2026-07-16","kind":"grant","planned":true,"acquired":true,"shares":33918,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The July 16, 2026 options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years.\nRemarks:"}],"balance_after":33918,"derivative":{"exercise_price":116.65,"expiration_date":"2036-07-15","underlying":"Common Stock","underlying_shares":33918},"source":{"system":"sec-edgar","filing":"0002050035-26-000011","document":"wk-form4_1784578149.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/879169/000205003526000011/wk-form4_1784578149.xml","form_type":"4"}},{"id":706037,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":29597,"kind":"person","name":"Issa Mohamed Khairie","position":1,"cik":"0002050035","reported_name":"Issa Mohamed Khairie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Head of U.S. Commercial"}}],"security":"Performance Shares","published_at":"2026-07-20T20:09:16.000Z","date":"2026-07-16","kind":"grant","planned":true,"acquired":true,"shares":19643,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each performance share represents the right to receive up to 200% of one share of common stock. Such shares may be earned based upon the issuer's relative total shareholder return (\"TSR\") over a three-year performance period beginning on January 1, 2026 as compared to the TSR of companies in a fixed peer group, as set forth in the Performance Share Award Agreement. The earned shares will\nvest on the third anniversary of the grant date subject to the Reporting Person's continued service with the issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each performance share represents the right to receive up to 200% of one share of common stock. Such shares may be earned based upon the issuer's relative total shareholder return (\"TSR\") over a three-year performance period beginning on January 1, 2026 as compared to the TSR of companies in a fixed peer group, as set forth in the Performance Share Award Agreement. The earned shares will\nvest on the third anniversary of the grant date subject to the Reporting Person's continued service with the issuer."}],"balance_after":19643,"derivative":{"expiration_date":"2029-07-16","underlying":"Common Stock","underlying_shares":19643},"source":{"system":"sec-edgar","filing":"0002050035-26-000011","document":"wk-form4_1784578149.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/879169/000205003526000011/wk-form4_1784578149.xml","form_type":"4"}},{"id":706036,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":29597,"kind":"person","name":"Issa Mohamed Khairie","position":1,"cik":"0002050035","reported_name":"Issa Mohamed Khairie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Head of U.S. Commercial"}}],"security":"Common Stock","published_at":"2026-07-20T20:09:16.000Z","date":"2026-07-16","kind":"grant","planned":true,"acquired":true,"shares":7857,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents award of restricted stock units (\"RSUs\") that will vest 25% annually over four years. The RSUs may be settled only for shares of common stock on a one-for-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Including the July 16, 2026 grant, this includes an aggregate of 71,797 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":71797,"source":{"system":"sec-edgar","filing":"0002050035-26-000011","document":"wk-form4_1784578149.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/879169/000205003526000011/wk-form4_1784578149.xml","form_type":"4"}},{"id":706035,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":29597,"kind":"person","name":"Issa Mohamed Khairie","position":1,"cik":"0002050035","reported_name":"Issa Mohamed Khairie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Head of U.S. Commercial"}}],"security":"Common Stock","published_at":"2026-07-20T20:09:16.000Z","date":"2026-07-16","kind":"sale","planned":true,"acquired":false,"shares":1093,"price":115.01,"value":125705.93,"ownership":{"direct":true},"balance_after":63940,"source":{"system":"sec-edgar","filing":"0002050035-26-000011","document":"wk-form4_1784578149.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000205003526000011/wk-form4_1784578149.xml","form_type":"4"}},{"id":708504,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":29597,"kind":"person","name":"Issa Mohamed Khairie","position":1,"cik":"0002050035","reported_name":"Issa Mohamed Khairie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Head of U.S. Commercial"}}],"security":"Common Stock","published_at":"2026-07-16T20:06:42.000Z","date":"2026-07-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":1099,"price":115.09,"value":126483.91,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld automatically by the Issuer to satisfy tax withholding obligations due at settlement of restricted stock units previously reported in Table I as common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This includes an aggregate of 63,940 shares of common stock issuable pursuant to previously reported RSUs that have not vested."}],"balance_after":65033,"source":{"system":"sec-edgar","filing":"0002050035-26-000009","document":"wk-form4_1784232398.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000205003526000009/wk-form4_1784232398.xml","form_type":"4"}},{"id":934720,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":29597,"kind":"person","name":"Issa Mohamed Khairie","position":1,"cik":"0002050035","reported_name":"Issa Mohamed Khairie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Head of US Oncology"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-01-21T21:06:10.000Z","date":"2026-01-16","kind":"grant","planned":false,"acquired":true,"shares":14237,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Beginning January 16, 2026, options become exercisable in 37 installments, with the first 25% vesting on July 15, 2026 and the remainder vesting monthly over three years."}],"balance_after":14237,"derivative":{"exercise_price":106.21,"expiration_date":"2036-01-15","underlying":"Common Stock","underlying_shares":14237},"source":{"system":"sec-edgar","filing":"0002050035-26-000004","document":"wk-form4_1769029568.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000205003526000004/wk-form4_1769029568.xml","form_type":"4"}},{"id":943668,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":29597,"kind":"person","name":"Issa Mohamed Khairie","position":1,"cik":"0002050035","reported_name":"Issa Mohamed Khairie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Head of US Oncology"}}],"security":"Common Stock","published_at":"2026-01-08T21:03:39.000Z","date":"2026-01-07","kind":"sale","planned":true,"acquired":false,"shares":10856,"price":109.07,"value":1184063.92,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This includes an aggregate of 66,132 shares of common stock issuable pursuant to previously reported RSUs that have not vested."}],"balance_after":66132,"source":{"system":"sec-edgar","filing":"0002050035-26-000002","document":"wk-form4_1767906216.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/879169/000205003526000002/wk-form4_1767906216.xml","form_type":"4"}},{"id":943667,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":29597,"kind":"person","name":"Issa Mohamed Khairie","position":1,"cik":"0002050035","reported_name":"Issa Mohamed Khairie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Head of US Oncology"}}],"security":"Common Stock","published_at":"2026-01-08T21:03:39.000Z","date":"2026-01-06","kind":"tax_withholding","planned":true,"acquired":false,"shares":8264,"price":106.66,"value":881438.24,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld automatically by the Issuer to satisfy tax withholding obligations due at settlement of restricted stock units previously reported in Table I as common stock."}],"balance_after":76988,"source":{"system":"sec-edgar","filing":"0002050035-26-000002","document":"wk-form4_1767906216.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000205003526000002/wk-form4_1767906216.xml","form_type":"4"}},{"id":1085952,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":29597,"kind":"person","name":"Issa Mohamed Khairie","position":1,"cik":"0002050035","reported_name":"Issa Mohamed Khairie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Head of US Oncology"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-07-17T20:04:17.000Z","date":"2025-07-15","kind":"grant","planned":false,"acquired":true,"shares":19735,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The July 15, 2025 options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years."}],"balance_after":19735,"derivative":{"exercise_price":68.25,"expiration_date":"2035-07-14","underlying":"Common Stock","underlying_shares":19735},"source":{"system":"sec-edgar","filing":"0000879169-25-000090","document":"wk-form4_1752782653.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/879169/000087916925000090/wk-form4_1752782653.xml","form_type":"4"}},{"id":1085951,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":29597,"kind":"person","name":"Issa Mohamed Khairie","position":1,"cik":"0002050035","reported_name":"Issa Mohamed Khairie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Head of US Oncology"}}],"security":"Performance Shares","published_at":"2025-07-17T20:04:17.000Z","date":"2025-07-15","kind":"grant","planned":false,"acquired":true,"shares":21923,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each performance share represents the right to receive up to 200% of one share of common stock. Such shares may be earned based upon the issuer's relative total shareholder return (\"TSR\") over a three-year performance period beginning on January 1, 2025 as compared to the TSR of companies in a fixed peer group, as set forth in the Performance Share Award Agreement. The earned shares will vest on the third anniversary of the grant date subject to the Reporting Person's continued service with the issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each performance share represents the right to receive up to 200% of one share of common stock. Such shares may be earned based upon the issuer's relative total shareholder return (\"TSR\") over a three-year performance period beginning on January 1, 2025 as compared to the TSR of companies in a fixed peer group, as set forth in the Performance Share Award Agreement. The earned shares will vest on the third anniversary of the grant date subject to the Reporting Person's continued service with the issuer."}],"balance_after":21923,"derivative":{"expiration_date":"2028-07-15","underlying":"Common Stock","underlying_shares":21923},"source":{"system":"sec-edgar","filing":"0000879169-25-000090","document":"wk-form4_1752782653.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/879169/000087916925000090/wk-form4_1752782653.xml","form_type":"4"}},{"id":1085950,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":29597,"kind":"person","name":"Issa Mohamed Khairie","position":1,"cik":"0002050035","reported_name":"Issa Mohamed Khairie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Head of US Oncology"}}],"security":"Common Stock","published_at":"2025-07-17T20:04:17.000Z","date":"2025-07-15","kind":"grant","planned":false,"acquired":true,"shares":8769,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents award of restricted stock units (\"RSUs\") that will vest 25% annually over four years. The RSUs may be settled only for shares of common stock on a one-for-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Including the July 15, 2025 grant, this includes an aggregate of 85,252 shares of common stock issuable pursuant to previously reported RSUs that have not vested."}],"balance_after":85252,"source":{"system":"sec-edgar","filing":"0000879169-25-000090","document":"wk-form4_1752782653.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000087916925000090/wk-form4_1752782653.xml","form_type":"4"}},{"id":1096671,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":29597,"kind":"person","name":"Issa Mohamed Khairie","position":1,"cik":"0002050035","reported_name":"Issa Mohamed Khairie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Head of US Oncology"}}],"security":"Common Stock","published_at":"2025-07-02T20:42:31.000Z","date":"2025-06-30","kind":"grant","planned":false,"acquired":true,"shares":27812,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents award of restricted stock units (\"RSUs\") that will vest 25% annually over four years from the vesting commencement date of January 6, 2025. The RSUs may be settled only for shares of common stock on a one-for-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Including the June 30, 2025 grant, this includes an aggregate of 76,483 shares of common stock issuable pursuant to previously reported RSUs that have not vested."}],"balance_after":76483,"source":{"system":"sec-edgar","filing":"0000879169-25-000068","document":"wk-form4_1751488914.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000087916925000068/wk-form4_1751488914.xml","form_type":"4"}},{"id":1307191,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":29597,"kind":"person","name":"Issa Mohamed Khairie","position":1,"cik":"0002050035","reported_name":"Issa Mohamed Khairie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Head of US Oncology"}}],"security":"Common Stock","published_at":"2025-01-08T21:11:08.000Z","date":"2025-01-06","kind":"grant","planned":false,"acquired":true,"shares":48671,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents award of restricted stock units (\"RSUs\") that will vest 25% annually over four years. The RSUs may be settled only for shares of common stock on a one-for-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes the January 6, 2025 aggregate grant of 48,671 shares of common stock."}],"balance_after":48671,"source":{"system":"sec-edgar","filing":"0000879169-25-000009","document":"wk-form4_1736370662.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000087916925000009/wk-form4_1736370662.xml","form_type":"4"}}]}